Join
Live feed
·
INSIDERFilingvia Quantisnow
Cytek Biosciences Inc. logo

Chief Financial Officer Mccombe William D. converted options into 25,719 shares and covered exercise/tax liability with 9,229 shares, increasing direct ownership by 17% to 111,177 units (SEC Form 4) (for tax liability)

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track CTKB (Cytek Biosciences Inc.) and more on Quantisnow.